Status:
COMPLETED
Symptom Management After Breast Cancer Surgery
Lead Sponsor:
University of California, San Francisco
Conditions:
Neuropathic Pain
Postmastectomy Pain
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast ...
Eligibility Criteria
Inclusion
- Adult women \>18 years who develop neuropathic pain in the breast scar area and/or ipsilateral arm following breast cancer surgery
- Has a healed incision(s)
- Has no recurrent disease in the painful area
- Is able to read, write and understand English
Exclusion
- Presence of another type of pain that is more severe than the neuropathic pain
- Use of an opioid analgesic of greater than 60 mg codeine/day
- Is actively trying to become pregnant
- Has a medical contraindication to the use of lidocaine
- Has an allergy to lidocaine
- Is taking a coanalgesic for neuropathic pain.
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00686127
Start Date
September 1 2003
End Date
December 1 2007
Last Update
June 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Comprehensive Cancer Center
San Francisco, California, United States, 94143